Arrowhead Pharmaceuticals (ARWR) announced its public offerings, pricing $625M of 0.00% convertible senior notes due in 2032 and 3.1M shares of common stock at $64.50 per share. Instead of common ...

This Corvette Z06 3LZ convertible from 2025 is about as new as it gets, and can be yours with less than 2,000 miles put on so far! The Corvette has seen a great deal of innovation since its ...

Looking ahead: The vast majority of Windows users already run Steam on 64-bit operating systems, even though the client has continued to support a legacy 32-bit version of Windows. That era is ending: ...

View post: Columbia Is Selling a 'Warm' and 'Comfortable' Fleece for 40% Off The 1955 Ford Thunderbird prioritized luxury, pioneering the "personal luxury car" segment. A 2010 restoration added new ...

Michele Saegesser has returned to her previous role as Viking's vice president, sales and national accounts. Saegesser had retired from the position last January. Milton Hugh, Viking's executive vice ...

PITTSBURGH — Former Vikings wide receiver Adam Thielen appears to have found his new team. One day after the Vikings released Thielen at the Minnesota native's request, ESPN's Adam Schefter and NFL ...

Palmer Luckey unveiled his new take on the Nintendo 64, which he said will include new and never-before-seen video game titles. The ModRetro M64 faced tariffs and manufacturing concerns, Luckey wrote ...

RALEIGH, N.C. (WTVD) -- Wake County Sheriff's Office (WCSO) is investigating Thursday morning after a driver was reportedly shot in the head. Deputies were called to US-64 westbound near Lizard Lick ...

ASP Isotopes, Inc. ( (ASPI)) has issued an announcement. On November 7, 2025, Quantum Leap Energy LLC, a subsidiary of ASP Isotopes Inc., announced a Convertible Note Purchase Agreement to issue and ...

A team of traders specializing in convertible bonds at multistrategy hedge fund LMR Partners is on track for record yearly gains as a surge in issuances and a pickup in corporate actions create a ...

Viking Therapeutics, Inc. is a clinical-stage biotech focused on metabolic and endocrine therapies, highlighted by its promising VK2735 obesity drug. VKTX's pipeline includes late-stage GLP-1/GIP ...

Eli Lilly is a leader in weight loss drugs, a market that may reach $95 billion by the end of the decade. Viking Therapeutics is heading toward the finish line with a drug that could compete with ...